Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing ...
The data we will present at ARVO underscore our commitment to advances in ophthalmology in general and our retinal portfolio in particular,” said Levi Garraway, M.D., Ph.D., chief medical officer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results